Image

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.

Eligibility

Participant Inclusion Criteria

Focus Group Participants

  • A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
  • ≥18 years old
  • Considering post-mastectomy breast reconstruction

RCT Participants (Patients)

  • A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
  • ≥18 years old
  • Considering post-mastectomy breast reconstruction
  • Have an appointment scheduled for consultation with a plastic surgery provider

RCT Participants (Physicians)

  • Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.

Participant Exclusion Criteria

Focus Group Participants

  • Not considering post-mastectomy breast reconstruction
  • Non-English proficiency

RCT Participants (Patients)

  • Not considering postmastectomy breast reconstruction
  • Recurrent or metastatic breast cancer
  • Male sex
  • Non-English proficiency

RCT Participants (Physicians)

  • Does not provide breast reconstruction care at least 50% of the time
  • Non-English proficiency

Study details
    Breast Cancer

NCT07335354

Memorial Sloan Kettering Cancer Center

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.